# FDA Inspection 699349 - Vanguard Health Systems Acquisition Subsidiary#7, Inc. dba - November 18, 2010

Source: https://www.keypedia.com/records/fda_inspections/vanguard-health-systems-acquisition-subsidiary7-inc-dba/caec8090-ad8c-409d-9a42-0051d6585f96
Source feed: FDA_Inspections

> FDA Inspection 699349 for Vanguard Health Systems Acquisition Subsidiary#7, Inc. dba on November 18, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 699349
- Company Name: Vanguard Health Systems Acquisition Subsidiary#7, Inc. dba
- Inspection Date: 2010-11-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 796153 - 2012-08-06](https://www.keypedia.com/records/fda_inspections/vanguard-health-systems-acquisition-subsidiary7-inc-dba/5d68b0e0-7b9b-43f3-bec6-5578cd31f0c6)
- [FDA Inspection 588489 - 2009-06-11](https://www.keypedia.com/records/fda_inspections/vanguard-health-systems-acquisition-subsidiary7-inc-dba/549afd70-e9c0-4758-afae-51be63576b83)

Company: https://www.keypedia.com/companies/vanguard-health-systems-acquisition-subsidiary7-inc-dba/4f7fdb41-e54e-47f8-8e3e-cd6b6dcbd133

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d